AWG
LFCR icon

Alpha Wave Global’s Lifecore Biomedical LFCR Stock Holding History

Alpha Wave Global’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-72,260
Closed -$509K – 36
2025
Q1 		$509K Sell
72,260
-44,278
-38% -$275K 0.23% 21
2024
Q4 		$866K Buy
+116,538
New +$744K 0.4% 18

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Alpha Wave Global's LFCR Position: Q2 2025 in Review

Alpha Wave Global sold out of Lifecore Biomedical (LFCR) in Q2 2025, closing a stake of 72,260 shares — an estimated $509K sold.

Alpha Wave Global first reported a position in LFCR in Q4 2024 and held it in 2 quarters. The position peaked at $866K in Q4 2024. 86 funds tracked by Wall St. Rank hold LFCR as of Q2 2025.

  • Alpha Wave Global reported no remaining Lifecore Biomedical position as of Q2 2025 after selling out during the quarter.
  • Alpha Wave Global sold 72,260 Lifecore Biomedical shares in Q2 2025, an estimated $509K.
  • Alpha Wave Global first reported a position in Lifecore Biomedical in Q4 2024 and held it in 2 quarters.
  • Alpha Wave Global's Lifecore Biomedical position peaked at $866K in Q4 2024.
  • 86 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2025.

Based on Alpha Wave Global's 13F filing for Q2 2025, filed 13 Aug 2025.